Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Shalini Arunogiri, Addiction Psychiatrist, Associate Professor, Monash University

GLP-1 drugs like Ozempic may lower the risk of addiction: new study

Alvaro Golzalez/Getty Images

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows.

Semaglutide (also known as Ozempic), liraglutide and tirzepatide (Wegovy) belong to a class of drugs called GLP-1 (glucagon-like peptide-1) receptor agonists. These mimic a hormone involved in regulating blood sugar and appetite.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.